This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML syringes. The contract has a ceiling value of $6,592.23 and an ultimate completion date of October 4, 2024. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,273.35, is for the delivery of LEQVIO 284 MG/1.5 ML syringes, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 17, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML medical products. The contract has a firm fixed price of $17,579.28 and a completion date of August 12, 2024. It is not set aside for any specific business type. AmerisourceBergen will be responsible for delivering these specialized medical supplies to support military treatment facilities and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of 4,565,255,024 units of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a ceiling value of $10,987.05. The contract has a firm fixed price pricing type and an ultimate completion date of August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, has...
This is a delivery order contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a firm fixed price of $13,640.10 and a completion date of December 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award is for the delivery of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The $9,093.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of LEQVIO 284 MG/1.5 ML syringes. This $4,394.82 delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to support the Department of Defense. The contract has an...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Department of Defense (DoD) Medical Supply Chain (VPDLATSMED-A). The contract is for $10,987.05 and provides the DoD with the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award has an ultimate completion date of July 25, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is valued at $6,592.23 and provides for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a period of performance through July 1, 2024.
AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,640.10, is a delivery order for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 15, 2025.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...